Cited by 165Genetics and Neurodevelopmental DisordersAutism Spectrum Disorder ResearchWilliams Syndrome Research

The neuroanatomy and neuroendocrinology of fragile X syndrome

Hessl, David, Rivera, Susan M., Reiss, Allan L.·2004·Mental Retardation and Developmental Disabilities Research Reviews

Abstract

Fragile X syndrome (FXS), caused by a single gene mutation on the X chromosome, offers a unique opportunity for investigation of gene-brain-behavior relationships. Recent advances in molecular genetics, human brain imaging, and behavioral studies have started to unravel the complex pathways leading to the cognitive, psychiatric, and physical features that are unique to this syndrome. In this article, we summarize studies focused on the neuroanatomy and neuroendocrinology of FXS. A review of structural imaging studies of individuals with the full mutation shows that several brain regions are enlarged, including the hippocampus, amygdala, caudate nucleus, and thalamus, even after controlling for overall brain volume. These regions mediate several cognitive and behavioral functions known to be aberrant in FXS such as memory and learning, information and sensory processing, and social and emotional behavior. Two regions, the cerebellar vermis, important for a variety of cognitive tasks and regulation of motor behavior, and the superior temporal gyrus, involved in processing complex auditory stimuli, are reported to be reduced in size relative to controls. Functional imaging, typically limited to females, has emphasized that individuals with FXS do not adequately recruit brain regions that are normally utilized by unaffected individuals to carry out various cognitive tasks, such as arithmetic processing or visual memory tasks. Finally, we review a number of neuroendocrine studies implicating hypothalamic dysfunction in FXS, including abnormal activation of the hypothalamic-pituitary-adrenal (HPA) axis. These studies may help to explain the abnormal stress responses, sleep abnormalities, and physical growth patterns commonly seen in affected individuals. In the future, innovative longitudinal studies to investigate development of neurobiologic and behavioral features over time, and ultimately empirical testing of pharmacological, behavioral, and even molecular genetic interventions using MRI are likely to yield significant positive changes in the lives of persons with FXS, as well as increase our understanding of the development of psychiatric and learning problems in the general population.

Integrity signals

Registry

Crossref · 10.1002/mrdd.20004

Cites

74 of 74 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Several lines of investigation point to dysregulation of the oxytocin system in fragile X syndrome.

    “Although the available data do not help differentiate between these two possibilities, several lines of investigation point to dysregulation of the OT system in FXS:”

    From Effects of intranasal oxytocin on social anxiety in males with fragile X syndrome (2012) · cites this paper as Hessl et al., 2004

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hessl, D., Rivera, S. M., & Reiss, A. L.
Affiliations
  • University of California, Davis (US)
  • Stanford Medicine (US)
Corresponding author
Reiss, Allan L.
Venue
Mental Retardation and Developmental Disabilities Research Reviews
Publisher
Wiley
Published
2004-02
Volume
10
Issue
1
Pages
17-24
ISSN
  • 1080-4013 (ISSN-L)
  • 1098-2779
OpenAlex
W2058528988
Cited by
165
References
74
Citations by year
2025: 2 · 2024: 5 · 2023: 2 · 2021: 2 · 2020: 5 · 2019: 5 · 2018: 5 · 2017: 13 · 2016: 7 · 2015: 2 · 2014: 9 · 2013: 11 · 2012: 13
FWCI
1.21
Type
journal article
Language
en
Open access
closed
Locations
  • Mental Retardation and Developmental Disabilities Research Reviews (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Life Sciences › Neuroscience › Developmental Neuroscience › Williams Syndrome Research
Keywords
fragile X syndrome, neuroanatomy, neuroendocrinology, hippocampus, amygdala, caudate nucleus, thalamus, cerebellar vermis, superior temporal gyrus, functional neuroimaging, hypothalamic dysfunction, hypothalamic-pituitary-adrenal axis, stress response, sleep abnormalities, growth patterns, gene-brain-behavior relationship
MeSH terms
Adolescent, Adult, Brain, Child, Endocrine Glands, Female, Fragile X Syndrome, Humans, Hydrocortisone, Magnetic Resonance Imaging, Male, Nervous System, Saliva, Cluster Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review